Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
CN Ignites 11th Batch of Drug GPO, Refines Price Difference Calculation
Recommend 45 Positive 84 Negative 19 |
||||
|
||||
|
The eleventh batch of the Group Purchasing Organization (GPO) of the pharmaceutical industry in Mainland China has recently been initiated, Shi Zihai, Deputy Director of the National Healthcare Security Administration (NHSA), stated at a press conference. The NHSA is researching to optimize specific rules, particularly in the selection rules, by refining the calculation "anchor point" for price differences. The lowest bid will no longer be simply taken as a reference. Meanwhile, for the selected company with the lowest bid, it must publicly explain the reasonableness of its bid and commit not to bid below cost. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
